Income Tax Expense (Benefit) in USD of BIO-TECHNE Corp from Q1 2010 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
BIO-TECHNE Corp quarterly/annual Income Tax Expense (Benefit) history and change rate from Q1 2010 to Q3 2025.
  • BIO-TECHNE Corp Income Tax Expense (Benefit) for the quarter ending 30 Sep 2025 was $9.81M, a 49.2% increase year-over-year.
  • BIO-TECHNE Corp Income Tax Expense (Benefit) for the twelve months ending 30 Sep 2025 was $28.3M, a 10.6% increase year-over-year.
  • BIO-TECHNE Corp annual Income Tax Expense (Benefit) for 2025 was $25.1M, a 42.5% increase from 2024.
  • BIO-TECHNE Corp annual Income Tax Expense (Benefit) for 2024 was $17.6M, a 67% decline from 2023.
  • BIO-TECHNE Corp annual Income Tax Expense (Benefit) for 2023 was $53.2M, a 39% increase from 2022.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Change (%)
Income Tax Expense (Benefit), Annual (USD)
Income Tax Expense (Benefit), YoY Annual Change (%)

BIO-TECHNE Corp Quarterly Income Tax Expense (Benefit) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 $28.3M $9.81M +$3.24M +49.2% 01 Jul 2025 30 Sep 2025 10-Q 05 Nov 2025
Q2 2025 $25.1M -$5.18M -$6.25M -583% 01 Apr 2025 30 Jun 2025 10-K 22 Aug 2025
Q1 2025 $31.3M $15.7M +$3.66M +30.4% 01 Jan 2025 31 Mar 2025 10-Q 08 May 2025
Q4 2024 $27.7M $7.99M +$2.06M +34.9% 01 Oct 2024 31 Dec 2024 10-Q 06 Feb 2025
Q3 2024 $25.6M $6.57M +$8.01M 01 Jul 2024 30 Sep 2024 10-Q 05 Nov 2025
Q2 2024 $17.6M $1.07M -$11.8M -91.6% 01 Apr 2024 30 Jun 2024 10-K 22 Aug 2025
Q1 2024 $29.3M $12M +$2.05M +20.5% 01 Jan 2024 31 Mar 2024 10-Q 08 May 2025
Q4 2023 $27.3M $5.92M -$10.5M -63.9% 01 Oct 2023 31 Dec 2023 10-Q 06 Feb 2025
Q3 2023 $37.8M -$1.44M -$15.4M -110% 01 Jul 2023 30 Sep 2023 10-Q 05 Nov 2024
Q2 2023 $53.2M $12.8M -$4.3M -25.1% 01 Apr 2023 30 Jun 2023 10-K 22 Aug 2025
Q1 2023 $57.5M $9.98M +$1.35M +15.6% 01 Jan 2023 31 Mar 2023 10-Q 06 May 2024
Q4 2022 $56.2M $16.4M +$2.3M +16.3% 01 Oct 2022 31 Dec 2022 10-Q 07 Feb 2024
Q3 2022 $53.9M $14M +$15.6M 01 Jul 2022 30 Sep 2022 10-Q 07 Nov 2023
Q2 2022 $38.3M $17.1M +$24.7M 01 Apr 2022 30 Jun 2022 10-K 22 Aug 2024
Q1 2022 $13.6M $8.63M +$8.68M 01 Jan 2022 31 Mar 2022 10-Q 08 May 2023
Q4 2021 $4.94M $14.1M +$3.9M +38.1% 01 Oct 2021 31 Dec 2021 10-Q 07 Feb 2023
Q3 2021 $1.05M -$1.6M -$7.54M -127% 01 Jul 2021 30 Sep 2021 10-Q 07 Nov 2022
Q2 2021 $8.59M -$7.53M -$10.2M -381% 01 Apr 2021 30 Jun 2021 10-K 23 Aug 2023
Q1 2021 $18.8M -$48K -$10.4M -100% 01 Jan 2021 31 Mar 2021 10-Q 09 May 2022
Q4 2020 $29.2M $10.2M -$20.5M -66.7% 01 Oct 2020 31 Dec 2020 10-Q 07 Feb 2022
Q3 2020 $49.7M $5.94M +$2.54M +74.4% 01 Jul 2020 30 Sep 2020 10-Q 08 Nov 2021
Q2 2020 $47.2M $2.68M -$3.65M -57.6% 01 Apr 2020 30 Jun 2020 10-K 24 Aug 2022
Q1 2020 $50.8M $10.4M +$5.17M +98.9% 01 Jan 2020 31 Mar 2020 10-Q 07 May 2021
Q4 2019 $45.7M $30.7M +$26.5M +629% 01 Oct 2019 31 Dec 2019 10-Q 08 Feb 2021
Q3 2019 $19.2M $3.41M +$3.23M +1762% 01 Jul 2019 30 Sep 2019 10-Q 09 Nov 2020
Q2 2019 $15.9M $6.33M -$8.24M -56.6% 01 Apr 2019 30 Jun 2019 10-K 25 Aug 2021
Q1 2019 $24.2M $5.22M -$21K -0.4% 01 Jan 2019 31 Mar 2019 10-Q 11 May 2020
Q4 2018 $24.2M $4.21M +$31.3M 01 Oct 2018 31 Dec 2018 10-Q 06 Feb 2020
Q3 2018 -$7.12M $183K -$6.92M -97.4% 01 Jul 2018 30 Sep 2018 10-Q 06 Nov 2019
Q2 2018 -$198K $14.6M +$4.33M +42.3% 01 Apr 2018 30 Jun 2018 10-K 26 Aug 2020
Q1 2018 -$4.53M $5.24M -$3.73M -41.6% 01 Jan 2018 31 Mar 2018 10-Q 07 May 2019
Q4 2017 -$800K -$27.1M -$34.8M -451% 01 Oct 2017 31 Dec 2017 10-Q 07 Feb 2019
Q3 2017 $34M $7.1M -$1.84M -20.6% 01 Jul 2017 30 Sep 2017 10-Q 07 Nov 2018
Q2 2017 $35.9M $10.2M -$1.91M -15.7% 01 Apr 2017 30 Jun 2017 10-K/A 06 Nov 2019
Q1 2017 $37.8M $8.97M -$3.23M -26.4% 01 Jan 2017 31 Mar 2017 10-Q 09 May 2018
Q4 2016 $41M $7.72M -$1.8M -18.9% 01 Oct 2016 31 Dec 2016 10-Q 08 Feb 2018
Q3 2016 $42.8M $8.94M -$197K -2.16% 01 Jul 2016 30 Sep 2016 10-Q 09 Nov 2017
Q2 2016 $43M $12.1M +$231K +1.94% 01 Apr 2016 30 Jun 2016 10-K 27 Aug 2018
Q1 2016 $42.8M $12.2M -$2.27M -15.7% 01 Jan 2016 31 Mar 2016 10-Q 10 May 2017
Q4 2015 $45M $9.52M +$169K +1.81% 01 Oct 2015 31 Dec 2015 10-Q 09 Feb 2017
Q3 2015 $44.9M $9.14M -$1.55M -14.5% 01 Jul 2015 30 Sep 2015 10-Q 09 Nov 2016
Q2 2015 $46.4M $11.9M -$714K -5.66% 01 Apr 2015 30 Jun 2015 10-K 07 Sep 2017
Q1 2015 $47.1M $14.5M +$41K +0.28% 01 Jan 2015 31 Mar 2015 10-Q 10 May 2016
Q4 2014 $47.1M $9.35M -$1.81M -16.2% 01 Oct 2014 31 Dec 2014 10-Q 09 Feb 2016
Q3 2014 $48.9M $10.7M -$1.54M -12.6% 01 Jul 2014 30 Sep 2014 10-Q 09 Nov 2015
Q2 2014 $50.4M $12.6M +$274K +2.22% 01 Apr 2014 30 Jun 2014 10-K 29 Aug 2016
Q1 2014 $50.2M $14.4M +$3.08M +27.1% 01 Jan 2014 31 Mar 2014 10-Q 11 May 2015
Q4 2013 $47.1M $11.2M -$919K -7.61% 01 Oct 2013 31 Dec 2013 10-Q 09 Feb 2015
Q3 2013 $48M $12.2M -$92K -0.75% 01 Jul 2013 30 Sep 2013 10-Q 10 Nov 2014
Q2 2013 $48.1M $12.4M -$1.02M -7.65% 01 Apr 2013 30 Jun 2013 10-K 31 Aug 2015
Q1 2013 $49.1M $11.3M -$101K -0.88% 01 Jan 2013 31 Mar 2013 10-Q 12 May 2014
Q4 2012 $49.2M $12.1M +$22K +0.18% 01 Oct 2012 31 Dec 2012 10-Q 04 Feb 2014
Q3 2012 $49.2M $12.3M -$661K -5.09% 01 Jul 2012 30 Sep 2012 10-Q 12 Nov 2013
Q2 2012 $49.9M $13.4M -$1.26M -8.63% 01 Apr 2012 30 Jun 2012 10-K 29 Aug 2014
Q1 2012 $51.1M $11.4M -$2.87M -20% 01 Jan 2012 31 Mar 2012 10-Q 10 May 2013
Q4 2011 $54M $12.1M +$921K +8.27% 01 Oct 2011 31 Dec 2011 10-Q 11 Feb 2013
Q3 2011 $53.1M $13M +$399K +3.17% 01 Jul 2011 30 Sep 2011 10-Q 09 Nov 2012
Q2 2011 $52.7M $14.6M 01 Apr 2011 30 Jun 2011 10-K 29 Aug 2013
Q1 2011 $14.3M +$5.27M +58.2% 01 Jan 2011 31 Mar 2011 10-Q 10 May 2012
Q4 2010 $11.1M 01 Oct 2010 31 Dec 2010 10-Q 07 Feb 2012
Q3 2010 $12.6M 01 Jul 2010 30 Sep 2010 10-Q 09 Nov 2011
Q1 2010 $9.05M 01 Jan 2010 31 Mar 2010 10-Q 10 May 2011

BIO-TECHNE Corp Annual Income Tax Expense (Benefit) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2025 $25.1M +$7.48M +42.5% 01 Jul 2024 30 Jun 2025 10-K 22 Aug 2025
2024 $17.6M -$35.6M -67% 01 Jul 2023 30 Jun 2024 10-K 22 Aug 2025
2023 $53.2M +$14.9M +39% 01 Jul 2022 30 Jun 2023 10-K 22 Aug 2025
2022 $38.3M +$29.7M +346% 01 Jul 2021 30 Jun 2022 10-K 22 Aug 2024
2021 $8.59M -$38.6M -81.8% 01 Jul 2020 30 Jun 2021 10-K 23 Aug 2023
2020 $47.2M +$31.2M +196% 01 Jul 2019 30 Jun 2020 10-K 24 Aug 2022
2019 $15.9M +$16.1M 01 Jul 2018 30 Jun 2019 10-K 25 Aug 2021
2018 -$198K -$36.1M -101% 01 Jul 2017 30 Jun 2018 10-K 26 Aug 2020
2017 $35.9M -$7.13M -16.6% 01 Jul 2016 30 Jun 2017 10-K/A 06 Nov 2019
2016 $43M -$3.42M -7.37% 01 Jul 2015 30 Jun 2016 10-K 27 Aug 2018
2015 $46.4M -$4.02M -7.96% 01 Jul 2014 30 Jun 2015 10-K 07 Sep 2017
2014 $50.4M +$2.34M +4.87% 01 Jul 2013 30 Jun 2014 10-K 29 Aug 2016
2013 $48.1M -$1.76M -3.54% 01 Jul 2012 30 Jun 2013 10-K 31 Aug 2015
2012 $49.9M -$2.82M -5.34% 01 Jul 2011 30 Jun 2012 10-K 29 Aug 2014
2011 $52.7M +$6.01M +12.9% 01 Jul 2010 30 Jun 2011 10-K 29 Aug 2013
2010 $46.7M 01 Jul 2009 30 Jun 2010 10-K 29 Aug 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.